Connor, Clark & Lunn Investment Management (CC&L)
AGTC

Connor, Clark & Lunn Investment Management (CC&L)’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-28,909
Closed -$118K – 1132
2020
Q4 		$118K Sell
28,909
-11,831
-29% -$58.1K ﹤0.01% 853
2020
Q3 		$198K Sell
40,740
-21,721
-35% -$119K ﹤0.01% 837
2020
Q2 		$346K Buy
62,461
+2,483
+4% +$11.4K ﹤0.01% 822
2020
Q1 		$197K Buy
+59,978
New +$316K ﹤0.01% 870
2019
Q1 		– Sell
-52,925
Closed -$132K – 1074
2018
Q4 		$132K Sell
52,925
-8,050
-13% -$47.1K ﹤0.01% 889
2018
Q3 		$445K Sell
60,975
-3,200
-5% -$14K ﹤0.01% 721
2018
Q2 		$237K Buy
64,175
+3,500
+6% +$16.2K ﹤0.01% 929
2018
Q1 		$234K Hold
60,675
– – ﹤0.01% 643
2017
Q4 		$218K Sell
60,675
-9,500
-14% -$35.9K ﹤0.01% 713
2017
Q3 		$277K Sell
70,175
-700
-1% -$3.21K ﹤0.01% 713
2017
Q2 		$361K Buy
70,875
+7,400
+12% +$41.6K ﹤0.01% 655
2017
Q1 		$438K Buy
63,475
+23,400
+58% +$183K ﹤0.01% 649
2016
Q4 		$375K Buy
40,075
+20,975
+110% +$189K ﹤0.01% 670
2016
Q3 		$187K Buy
+19,100
New +$258K ﹤0.01% 740
2016
Q1 		– Sell
-12,950
Closed -$264K – 925
2015
Q4 		$264K Sell
12,950
-100
-0.8% -$1.54K ﹤0.01% 653
2015
Q3 		$171K Buy
+13,050
New +$216K ﹤0.01% 653

Other funds holding AGTC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s AGTC Position: Q1 2021 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2021, closing a stake of 28,909 shares — an estimated $118K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AGTC in Q3 2015 and held it in 16 quarters. The position peaked at $445K in Q3 2018. 82 funds tracked by Wall St. Rank hold AGTC as of Q1 2021.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Applied Genetic Technologies Corporation position as of Q1 2021 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 28,909 Applied Genetic Technologies Corporation shares in Q1 2021, an estimated $118K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Applied Genetic Technologies Corporation in Q3 2015 and held it in 16 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Applied Genetic Technologies Corporation position peaked at $445K in Q3 2018.
  • 82 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2021.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2021, filed 13 May 2021.